New patent for IMPAX drug TWINJECT 0.3

Annual Drug Patent Expirations for TWINJECT+0.3 Twinject 0.3 is a drug marketed by Impax and is included in one NDA. It is available from four suppliers. There are two patents…

The post New patent for IMPAX drug TWINJECT 0.3 appeared first on DrugPatentWatch - Make Better Decisions.


Comments are closed.

Biotechblog